Marly van Assen

Adrit Rao, Malte Jensen, Andrea T. Fisher et al.

Artificial intelligence allows automatic extraction of imaging biomarkers from already-acquired radiologic images. This paradigm of opportunistic imaging adds value to medical imaging without additional imaging costs or patient radiation exposure. However, many open-source image analysis solutions lack rigorous validation while commercial solutions lack transparency, leading to unexpected failures when deployed. Here, we report development and validation for two of the first fully open-sourced, FDA-510(k)-cleared deep learning pipelines to mitigate both challenges: Abdominal Aortic Quantification (AAQ) and Bone Mineral Density (BMD) estimation are both offered within the Comp2Comp package for opportunistic analysis of computed tomography scans. AAQ segments the abdominal aorta to assess aneurysm size; BMD segments vertebral bodies to estimate trabecular bone density and osteoporosis risk. AAQ-derived maximal aortic diameters were compared against radiologist ground-truth measurements on 258 patient scans enriched for abdominal aortic aneurysms from four external institutions. BMD binary classifications (low vs. normal bone density) were compared against concurrent DXA scan ground truths obtained on 371 patient scans from four external institutions. AAQ had an overall mean absolute error of 1.57 mm (95% CI 1.38-1.80 mm). BMD had a sensitivity of 81.0% (95% CI 74.0-86.8%) and specificity of 78.4% (95% CI 72.3-83.7%). Comp2Comp AAQ and BMD demonstrated sufficient accuracy for clinical use. Open-sourcing these algorithms improves transparency of typically opaque FDA clearance processes, allows hospitals to test the algorithms before cumbersome clinical pilots, and provides researchers with best-in-class methods.

Theodorus Dapamede, Aisha Urooj, Vedant Joshi et al.

Women are underdiagnosed and undertreated for cardiovascular disease. Automatic quantification of breast arterial calcification on screening mammography can identify women at risk for cardiovascular disease and enable earlier treatment and management of disease. In this retrospective study of 116,135 women from two healthcare systems, a transformer-based neural network quantified BAC severity (no BAC, mild, moderate, and severe) on screening mammograms. Outcomes included major adverse cardiovascular events (MACE) and all-cause mortality. BAC severity was independently associated with MACE after adjusting for cardiovascular risk factors, with increasing hazard ratios from mild (HR 1.18-1.22), moderate (HR 1.38-1.47), to severe BAC (HR 2.03-2.22) across datasets (all p<0.001). This association remained significant across all age groups, with even mild BAC indicating increased risk in women under 50. BAC remained an independent predictor when analyzed alongside ASCVD risk scores, showing significant associations with myocardial infarction, stroke, heart failure, and mortality (all p<0.005). Automated BAC quantification enables opportunistic cardiovascular risk assessment during routine mammography without additional radiation or cost. This approach provides value beyond traditional risk factors, particularly in younger women, offering potential for early CVD risk stratification in the millions of women undergoing annual mammography.

Roy M. Gabriel, Mohammadreza Zandehshahvar, Marly van Assen et al.

To reduce the amount of required labeled data for lung disease severity classification from chest X-rays (CXRs) under class imbalance, this study applied deep active learning with a Bayesian Neural Network (BNN) approximation and weighted loss function. This retrospective study collected 2,319 CXRs from 963 patients (mean age, 59.2 $\pm$ 16.6 years; 481 female) at Emory Healthcare affiliated hospitals between January and November 2020. All patients had clinically confirmed COVID-19. Each CXR was independently labeled by 3 to 6 board-certified radiologists as normal, moderate, or severe. A deep neural network with Monte Carlo Dropout was trained using active learning to classify disease severity. Various acquisition functions were used to iteratively select the most informative samples from an unlabeled pool. Performance was evaluated using accuracy, area under the receiver operating characteristic curve (AU ROC), and area under the precision-recall curve (AU PRC). Training time and acquisition time were recorded. Statistical analysis included descriptive metrics and performance comparisons across acquisition strategies. Entropy Sampling achieved 93.7% accuracy (AU ROC, 0.91) in binary classification (normal vs. diseased) using 15.4% of the training data. In the multi-class setting, Mean STD sampling achieved 70.3% accuracy (AU ROC, 0.86) using 23.1% of the labeled data. These methods outperformed more complex and computationally expensive acquisition functions and significantly reduced labeling needs. Deep active learning with BNN approximation and weighted loss effectively reduces labeled data requirements while addressing class imbalance, maintaining or exceeding diagnostic performance.